REDWOOD CITY, Calif., July 02, 2026 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a late-stage clinical oncology company developing targeted therapies for patients with RAS-addicted ...

Robot vacuums have come a long way over the past several years, with some of the most advanced models nowadays going well and beyond anything we thought they’d be able to do. But, in a lot of cases, ...

The Army in the next four to six weeks plans to set up at least two domestic ranges that mimic realistic conditions on Ukraine battlefields, according to Army Secretary Dan Driscoll. "You can have a ...

My Alerts is a service for subscribers. Please login or subscribe in order to use My Alerts. More than 50 people were injured and 18 remain missing after an explosion and fire occurred on Sunday at ...

Authorities confirm deaths, say 66 injured Authorities say a 'technical accident' caused explosion Blast occurred during restart at Barzan gas supply facility DOHA, June 22 (Reuters) - Thirteen people ...

The Monument of Triumph update to Destiny 2 brought back a frankly absurd amount of old weapons, including the Pyroclastic Flow Rocket Launcher. Not seen since Season of the Dawn, a full 20 seasons ...

Polygon Nintendo Direct Game reveals, trailers, and what’s next from the house that Mario built. Get more news→ 2D sprites moving in a 3D plane has been the hot new trend for Japanese roleplaying ...

An investigational oral drug that targets RAS, the dominant oncogenic driver in pancreatic cancer, nearly doubled overall survival compared with common second-line chemotherapy regimens in patients ...

This year’s meeting of the American Society of Clinical Oncology is abuzz with talk of RAS inhibitors, largely driven by Revolution Medicines’ barnburner pancreatic cancer data drop earlier this year.

PCWorld tested the $1,500 Narwal Flow 2 robot vacuum/mop against eight challenging messes including raw egg, olive oil, coffee spills, and mud to evaluate its premium cleaning capabilities. The device ...

Structured exercise program following adjuvant chemotherapy for colon cancer: A cost-utility analysis of the CHALLENGE trial. Circulating tumor DNA (ctDNA) clearance as an early indicator of sotorasib ...

After debunking earlier rumors that it was acquiring RAS superstar Revolution Medicines, AbbVie is now taking a more definitive step into the red-hot cancer field. The Chicago pharma has agreed to ...